Amgen Reimbursement Connection® provides personalized support regarding reimbursement policies, coding and billing procedures. Prior authorization and claims appeals for Amgen products such as Aranesp® (darbepoetin alfa), Neulasta™ (pegfilgrastim), NEUPOGEN® (Filgrastim) and EPOGEN® (for dialysis patients). One call helps resolve issues and obtain reimbursement results.

When calling the Reimbursement Connection® be prepared with the following information:

• Patient consent to disclose patient-identifiable and medical information (required)
• Name and address of the physician
• Date of service
• Patient's name and ID number
• Name and address of insurer
• Insurer's reason for rejecting the claim (if applicable)
• Copy of the claim or explanation of benefits
• (EOB), (if applicable)

The Reimbursement Connection® provides:

• Coverage requirements for Aranesp® and Neulasta™ and NEUPOGEN®
• Reviews claims for EPOGEN® (dialysis patients only)
• Provides coding and billing assistance
• Explains payor reimbursement policies
• Provides prior authorization support
• Provides information regarding claims appeal procedures
• Helps to identify alternative sources of payment
• Provides information regarding the Amgen
• SAFETY NET® Program for medically needy patients

CONTACT INFORMATION

800-272-9376 | Mon. - Fri. 9 AM to 8 PM (ET) | www.reimbursementconnection.com